TTP BUILDS ON STRONG FOUNDATIONS FOR FURTHER GROWTH
Tom Kirkwood, who recently resigned as TTP’s Chief Executive of Strategic Development in order to pursue other interests, has left the company in a position of unprecedented strength as the UK’s leading treatment provider. He was one of the organisation’s founding shareholders, joining in 2006 and playing a significant role its unrivalled growth over the past seven years.
The company is now in the process of putting its dynamic new management team in place, including some of the industry’s leading figures. This will leave it ideally placed to both reinforce its position as the country’s top treatment provider and firmly establish the building blocks needed for this further phase of growth.
Yet another exciting prospect for the group is the emergence of One40 as a treatment provider of choice in the private sector. Headed up by Michael Garnham and having the vastly experienced David Smallwood recently appointed as Treatment Director, One40, though autonomous and with its own independent board in place, will draw on the vast experience of its sister companies and provide individually tailored premium treatment programmes.
Underpinning both management teams will be the newly formed Landre Group Services, a highly specialised private equity vehicle specifically designed to provide compliance, accounting, human resources, facility management and, most importantly, the funding to enable all divisions to thrive and grow in this ever changing market.
More details are available at: